ALEXANDER MULE: Open Payments
NPI 1649744665 · COSTA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,173 in 139 payments from 18 companies in 2025. Trend: 2023 $8,101 · 2024 $5,042 · 2025 $3,173
Food & beverage: $3,173
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 19 | $613 |
| Neurocrine BioSciences, Inc. | 15 | $418 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $394 |
| Otsuka America Pharmaceutical, Inc. | 9 | $236 |
| E.R. Squibb & Sons, L.L.C. | 10 | $213 |
| Axsome Therapeutics, Inc. | 9 | $203 |
| Janssen Pharmaceuticals, Inc | 7 | $197 |
| Alkermes, Inc. | 14 | $169 |
| Lundbeck LLC | 8 | $165 |
| Teva Pharmaceuticals USA, Inc. | 9 | $164 |
Products named: HETLIOZ, INGREZZA, CAPLYTA, ABILIFY ASIMTUFII, COBENFY, Auvelity, SPRAVATO, REXULTI.
Industry payments across CA — which companies pay providers there.
